how many americans are taking glp-1 Big shift in U.S. health! A new Gallup poll shows 11% of now drugs, coinciding with obesity rates dropping to 36.4% (down from 39.9% in 2022). Promising progress in US households with GLP-1 users
Description
HRTS offers exposure to companies advancing cardiology, metabolic diseases, and GLP-1s.
We explore the underlying biological mechanisms, summarize clinical trial evidence, and highlight emerging applications in non-diabetic populations
But among patients who stopped it, two-thirds regained most of their weight within a year
What does the current research show
(equal to one in 3 U.S
Despite the ongoing legal battle that GLP-1 agonists have, they are widely used and prescribed even with the side effects they can cause
